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The fatality of avian influenza A(H7N9) infection in humans was over 30%. To identify human genetic
susceptibility to A(H7N9) infection, we performed a genome-wide association study (GWAS) involving 102
A(H7N9) patients and 106 heavily-exposed healthy poultry workers, a sample size critically restricted by the
small number of human A(H7N9) cases. To tackle the stringent significance cutoff of GWAS, we utilized an
artificial imputation programSnipSnip to improve the association signals. In single-SNP analysis, one of the
top SNPs was rs13057866 of LGALS1. The artificial imputation (AI) identified three non-genotyped causal
variants, which can be represented by three anchor/partner SNP pairs rs13057866/rs9622682 (AI P51.813
1027), rs4820294/rs2899292 (2.133 1027) and rs62236673/rs2899292 (4.253 1027) respectively. Haplotype
analysis of rs4820294 and rs2899292 could simulate the signal of a causal variant. The rs4820294/rs2899292
haplotype GG, in association with protection from A(H7N9) infection (OR 5 0.26, P 5 5.92 3 1027)
correlated to significantly higher levels of LGALS1mRNA (P5 0.050) and protein expression (P5 0.025) in
lymphoblast cell lines. Additionally, rs4820294 was mapped as an eQTL in human primary monocytes and
lung tissues. In conclusion, functional variants of LGALS1 causing the expression variations are
contributable to the differential susceptibility to influenza A(H7N9).
A
novel reassortant avian influenza A virus H7N9 [A(H7N9)] has caused human infections since the spring
of 20131–3. As of July 7th 2014, there had been a total of 451 laboratory-confirmed cases, including at least
156 deaths4, which was about ten-fold of the case number of humanH5N1 infection in the past 11 years in
China5. The over 30% case-fatality rate of A(H7N9) infection is greater than that of the SARS coronavirus
outbreak in 2003 and similar to the ongoing MERS coronavirus outbreak6,7. Clinically, most A(H7N9) patients
exhibited lower respiratory tract infection, some of them complicated with multi-organ dysfunction; whilst a
small portion of patients, basically children and young adults exhibited mild symptoms2,8,9.
Most A(H7N9) patients had a recent history of poultry contact5. In fact, exposure to domestic poultries is not rare
in both rural and urban settings10. Many studies demonstrated that the pathogenicity of influenza virus is code-
termined by both host and virus genetics. Since the A(H7N9) outbreak, multiple isolates have been recovered from
human, poultry and environment, designated into more than twenty genotypes. Moreover, the genetic heterogen-
eity increased along with virus spread and transmission11. However, there has been little evidence showing the
remarkable difference in virulence or infectivity among various strains. Therefore, we speculated whether human
genetic variations may cause differential susceptibility to A(H7N9) infection. Human genetic predisposition to
influenza infection and development of severe disease upon infection has been underscored by World Health
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Organization and the scientific community. The familial clustering of
human A(H5N1) infection among blood relatives argued for a pos-
sible genetic susceptibility to the infection12. Furthermore, accumulat-
ing evidence demonstrated that human genetic polymorphisms
contribute to the outcome and disease severity of influenza infection.
We and others have demonstrated that genetic polymorphisms of
IFITM3, SFTPB and CD55 gene may contribute to the disease severity
of 2009 pandemic H1N1 influenza13–15. The same variant, rs12252 of
IFITM3, was associated with disease progression of human H7N9
infection16. However, the comprehensive understanding of genetic
susceptibility to novel A(H7N9) infection remained largely elusive.
Genome-wide association study (GWAS) has been widely utilized
to uncover the genetic basis of human diseases. However, compared
to other prevalent diseases, the relative small number of human
A(H7N9) influenza cases posed a considerable difficulty to the study
of genetic susceptibility to the infection. With a total of less than 400
cases of human A(H7N9) infection when we started the study, we
managed to obtain the genomic DNA samples of 102 Chinese
patients from Southern China. With a sample size at this level, it is
unlikely to identify an association variant with genome-wide signifi-
cance, i.e. 53 1028, unless the effect size is very large (e.g. odds ratio
of more than 3). Despite the existing difficulty, we proceeded to
GWAS since it allows the comprehensive understanding of the pos-
sible genetic determinism of human A(H7N9) influenza in an
unbiased manner. We performed a GWAS in 102 A(H7N9) patients
and 106 local healthy poultry workers, who have been intensively
exposed to A(H7N9) viruses without clinical evidence of infection.
To tackle the stringent significance cutoff of GWAS, we utilized
various approaches to analyze GWAS data. We applied an artificial
imputation program SnipSnip17 to improve the association signals
and facilitate the discovery of association variants. We performed
pathway-based analysis to uncover the biological pathways associated
with the higher risk to A(H7N9) infection. The expression quantitat-
ive trait loci (eQTL) mapping was also leveraged to facilitate the
identification of the association variants. We demonstrated that gen-
etic variations in lectin, galactoside-binding, soluble, 1 (LGALS1, also
known as Galectin 1) are contributable to the differential susceptibil-
ity to A(H7N9) influenza. Moreover, two biological pathways, extra-
cellular matrix (ECM)-receptor interaction and mitogen-activated
protein kinase (MAPK) signaling are significantly enriched pathways
associated with the susceptibility to influenza A(H7N9) infection.
Results
Epidemiological characteristics of A(H7N9) patients and poultry
workers. A total of 102 laboratory-confirmed A(H7N9) patients
were included in this study (Table 1). Among these patients, 98%
Table 1 | Demographic and clinical characteristics of A(H7N9) patients
Characteristicsa Death(n 5 27) Survival(n 5 75) P-valued
Demographics
Age (years) 66 (61–72) 58 (46–66) 0.002
Female sex 8 (29.6) 27 (36.0) 0.640
Risk conditionsb
Age $ 65 15 (57.7) 24 (32.0) 0.034
Pregnant women 0 (0) 1 (1.3) 1.000
Chronic pulmonary diseases 4 (14.8) 2 (2.7) 0.041
Chronic cardiac diseases 3 (11.1) 4 (5.3) 0.378
Metabolic disorders 4 (14.8) 5 (6.7) 0.240
Chronic renal diseases 1 (3.7) 3 (4.0) 1.000
Chronic hepatic diseases 0 (0) 1 (1.3) 1.000
Neurological conditions 2 (7.4) 4 (5.3) 0.654
Immunosuppression 3 (11.1) 2 (2.7) 0.114
Laboratory findings on admission
Hemoglobin (g/L) 108 (90–125) 124 (110–135) 0.014
Total white blood cell (3109 cells/L) 5.4 (1.8–11.4) 4.1 (3.0–6.1) 0.428
Neutrophil (3109 cells/L) 3.4 (1.4–10.2) 3.3 (2.1–4.9) 0.776
Lymphocyte (3109 cells/L) 0.60 (0.30–0.80) 0.50 (0.40–0.70) 0.272
Platelet (3109 cells/L) 98 (61–184) 128 (93–162) 0.262
Prothrombin time (s) 13.0 (12.1–14.3) 12.5 (12.0–13.6) 0.154
Activated partial thromboplastin time (s) 38.3 (33.7–44.4) 36.0 (30.5–42.2) 0.607
D-dimer (mg/L) 7594 (5780–13900) 2190 (1260–5810) ,0.001
Urea (mmol/L) 8.9 (5.9–16.2) 4.6 (3.3–7.3) 0.001
Creatinine (mmol/L) 88 (70–170) 61 (47–82) ,0.001
Bilirubin (mmol/L) 11.0 (8.8–16.6) 8.0 (6.0–12.0) ,0.001
Alanine transaminase (U/L) 39 (27–65) 33 (21–55) 0.174
Aspartate transaminase (U/L) 87 (39–147) 49 (35–74) 0.002
Lactate dehydrogenase (U/L) 670 (569–873) 394 (309–549) ,0.001
Creatine kinase (U/L) 263 (140–630) 152 (74–301) 0.032
C-reactive protein (mg/L) 113 (78–153) 57 (28–102) 0.001
Clinical Outcome
ICU admission 26 (96.3) 68 (90.7) 0.678
APACHE II scorec 27 (25–30) 18 (16–22) ,0.001
ARDS 25 (92.6) 49 (65.3) 0.006
MODS 23 (85.2) 10 (13.3) ,0.001
ECMO 6 (22.2) 8 (10.7) 0.190
APACHE II, Acute Physiology and Chronic Health Evaluation II; ARDS, acute respiratory distress syndrome; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; MODS, multi-organ
dysfunction syndrome.
aAll continuous variables are expressed as median (interquartile range).
bObesity or hemoglobinopathy were not present in any individuals.
cData only included patients who were admitted to the intensive care unit.
dFisher exact test and Mann Whitney U test were used for categorical variables and continuous variables, respectively.
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(100/102) required oxygen supplementation, 92% (94/102) were
admitted to the intensive care unit, 73% (74/102) had acute
respiratory distress syndrome (ARDS), 32% (33/102) had multi-
organ dysfunction syndrome (MODS) and 26% (27/102) died.
When compared to those who survived, patients who died were
significantly older, with more incidence of chronic pulmonary
diseases and significantly higher levels of urea, creatinine,
bilirubin, aspartate transaminase, lactate dehydrogenase, creatine
kinase, C-reactive protein and d-dimer, as well as the higher Acute
Physiology and Chronic Health Evaluation (APACHE) II score, but
significantly lower levels of hemoglobin.
A total of 106 healthy poultry workers were included as controls.
These healthy poultry workers were intentionally recruited since they
were the most comparable population to A(H7N9) patients in terms
of the virus exposure, the key determinant for human A(H7N9)
infection. There was no significant difference in the proportion of
female between the A(H7N9) cases and poultry worker controls
(34% (35/102) vs 35% (37/106), P 5 1.000). However, the
A(H7N9) patients were significantly older than the poultry worker
controls (median age: 61 years [interquartile range, 50, 68 years] vs
48.5 years [interquartile range, 46 , 53 years]; P , 0.001). Our
attempt to recruit age-comparable controls for the patients was
unsuccessful due to the job requirement for poultry workers; since
poultry trafficking and transaction involve numerous physically-
challenging labors, whichwould be too demanding for people at their
sixties.
Identification of genetic variants associated with A(H7N9) infection.
HumanOmniZhongHua-8 BeadChips were applied to genotype all
study participants, with genotype calling rate .99%. The genome-
wide genotyping data were analyzed for the allelic association. The
top SNP, rs1960384, an intronic variant in C8B gene, and rs13057866,
a SNP 2 kb upstream of LGALS1, had allelic association P value of
2.073 1026 and 2.753 1026, respectively. As expected, none of SNPs
met the significance threshold for GWAS. We performed the
standard imputation in the study participants, in 0.2 Mb region
around the two candidate loci in C8B and LGALS1. The top SNPs
were rs1960384 (C8B) and rs71646553 (supplementary Table 1).
rs71646553, an indel 8 kb upstream of LGALS1, surfaced from the
imputation with slightly increased association signal (P 5 2.72 3
1026), probably due to its high linkage disequilibrium (LD) with
rs13057866 (Figure 1, r2 5 1.0 in Chinese and r2 5 0.98 in Asian).
A software implementation, SnipSnip, has been recently designed
to increase the association signal of poorly-tagged or non-genotyped
Figure 1 | Linkage disequilibrium pattern of three anchor SNPs rs4820294, rs13057866, rs62236773 and the related variants. The LD pattern of three
anchor SNPs rs13057866, rs4820294, rs62236673 (in green color) and partner SNP rs2899292 are plotted for 208 study participants in this study (H7N9).
The LD patterns of the three anchor SNPs and their high LD variants are plotted for 94 individuals from Chinese Han in Beijing (CHB), 264 individuals
from Asian (ASN), and 172 individuals from America (AMR), whose genotypes are retrieved from 1000 Genomes Project. The boxes are colored
according to D9measure on a white and red scale where red indicates complete LD (D’5 1). The numbers inside the boxes are r2 measure. The red box
without number indicates the highest r2 of 1.0.
www.nature.com/scientificreports
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causal variant by combinational analysis of two genotyped SNPs (an
anchor SNP and a partner SNP) in weak linkage disequilibrium with
the causal variant17. The software uses a sophisticated algorithm to
select an optimal nearby partner SNP for each anchor SNP based on
the correlation between the two SNPs. In simulation studies, the
program successfully identified causal variants which would other-
wise be missed by the conventional single-SNP analysis17. In this
study, all variants in our GWAS dataset were subject to SnipSnip
analysis. As shown in Figure 2, SnipSnip implementation substan-
tially increased the association signals compared to the traditional
single-SNP analysis. Interestingly, the top 4 causal variants were
mapped toC8B and LGALS1 (Table 2), the identical genes discovered
in single-SNP analysis as top candidates. The artificial imputation
(AI) P value (6.723 1028) of the top association signal, a variant of
C8B, marginally met the genome-wide significance threshold; while
the AI P values of the next three variants, which were mapped to
LGALS1, fell at 1027 level. Despite the failure to achieve genome-wide
significance for variants of LGALS1, our results did yield variants
with higher statistical significance than would be expected by chance
as shown in Q-Q plot of our data (supplementary Figure 1). The two
C8B variants, rs1960384 (the top SNP) and rs646606 (the anchor
SNP) are both intronic SNPs. There has been little evidence implic-
ating the functional alteration related to these two variants. On con-
trary, the anti-influenza activity of LGALS1 has been demonstrated
in a recent study18. In this study, three out of the top four association
variants from SnipSnip analysis were mapped to LGALS1. Therefore,
we focused on LGALS1 to explore the possible functional mechanism
underlying the genetic associations.
The in-depth analysis of association variants in LGALS1 and the
functional validation. Notably, three variants of LGALS1 were
associated with the susceptibility to A(H7N9) infection (Table 2).
Among the three anchor SNPs, rs4820294 and rs62236673 were in
high LD in our study participants (r25 0.98) and other populations
(r2 5 1.0, Figure 1), indicating the anchor/partner pair rs4820294/
rs2899292 and rs62236673/rs2899292 captured the identical causal
variant.We chose one pair rs4820294/rs2899292 for further analysis.
The causal variant captured by SnipSnip analysis was represented as
an anchor/partner pair, which are in weak LDwith causal variant but
can optimally capture the association signal for the latter. Although
AI P values of causal variants are illustrated in Table 2, we are
unaware of their distribution in the patient and control group;
neither can we postulate the possible molecular mechanism
underlying the associations. Now that the anchor and partner SNP
are in weak LDwith the causal variant, we inferred the distribution of
the causal variant by haplotype analysis of the anchor and partner
SNP although the association and distribution of anchor/partner
haplotypes as surrogate for those of non-genotyped causal variant
Figure 2 | The artificial imputation implemented in SnipSnip increased the association signal compared with single-SNP analysis. Manhattan plots
show P values of SNPs (y-axis, -log10 scale) on a genomic scale (x axis) of A(H7N9) GWAS dataset. The single-SNP allelic association P values using
logistic regression implemented in PLINK and artificial imputation P values using SnipSnip are shown in the upper and lower panel respectively.
www.nature.com/scientificreports
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may be an underestimation17. We simulated the association signal of
the causal variant by haplotype analysis of anchor/partner pair
rs4820294/rs2899292. As shown in Table 3, due to the LD between
rs4820294 and rs2899292 (Figure 1; A(H7N9)), the haplotype AA
was rarely present in our study subjects with an overall frequency of
less than 2%. The strongest association signal was haplotype GG,
which was significantly overrepresented in controls (35.58%) than
in A(H7N9) patients (14.33%). The odds ratio of 0.26 for haplotype
GG with the liability to infection can be translated into a more
comprehensible interpretation that carriers of this haplotype were
conferred 3.84 (95%CI, 2.24–6.58) fold of protection fromA(H7N9)
infection compared with non-carriers (P 5 5.92 3 1027). The
approximation of the P value of rs4820294/rs2899292 haplotype
GG to the AI P value of rs4820294/rs2899292 (2.13 3 1027)
suggested that the haplotype GG can appropriately simulate the
signal of causal variant represented by SNP pair rs4820294/
rs2899292. The identification of rs4820294/rs2899292 haplotype
GG was literally an advantage of SnipSnip over other commonly-
used imputation softwares since SnipSnip can capture the association
signals when they derive from a genuine haplotype effect but not to
the effect of any ungenotyped single-locus variant.
In UCSC genome browser (http://genome.ucsc.edu/), the promoter
region of LGALS1 that accommodates rs4820294, is a conserved reg-
ulatory region with strong signals for transcriptional factor binding
and DNase hypersensitivity based on the annotation of Encyclopedia
of DNA elements (ENCODE) Consortium (Figure 3), an inter-
national collaboration to functionally annotate human genome. We
inferred that rs4820294 and its related variants might affect the
expression regulation of LGALS1. We retrieved LGALS1 mRNA
expression data of lymphoblast cell lines (LCLs) from 74 Chinese
individuals from Genevar (GENe Expression VARiation) eQTL
(expression quantitative trait loci) database19, and corresponding gen-
otyping data from 1000 Genomes Project, to assess the possible hap-
lotype-expression correlation. We found that rs4820294/rs2899292
haplotype GG exhibited higher LGALS1 mRNA expression in these
74 LCLs. The LGALS1mRNA level in LCLs significantly correlated to
the carriage status of haplotype GG, i.e., homozygous-, heterozygous-
and non-carriage, by linear regression analysis (P 5 0.050, Figure 4a
& Table 3). To verify the haplotype-expression correlation in the
protein level, we chose 21 LCLs with three distinct carriage statuses
of rs4820294/rs2899292 haplotype GG and examined intracellular
LGALS1 protein expression levels by flow cytometry analysis.
Consistent with the result of eQTL mapping, LCLs carrying homo-
zygous haplotype GG exhibited the highest levels of LGALS1 protein
(Figure 4b, P5 0.025). Therefore, the higher LGALS1 expression level
of rs4820294/rs2899292 haplotype GG may represent the molecular
underpinning for its genetic association with the resistance to
A(H7N9) infection.
LCLs are immortalized cell lines derived from EBV-transformed
human B lymphocytes. We proceeded to examine the LGALS1
expression in primary human cells and tissues. Based on our obser-
vation with flow cytometry, LGALS1 protein levels were higher in
peripheral blood monocytes than in lymphocytes (unpublished
data). We isolated monocytes from peripheral blood mononuclear
cells to assay levels of LGALS1 transcript by RT-qPCR. We found
that rs4820294 per sewas an eQTL in human peripheral bloodmono-
cytes. As shown in Figure 4c, the rs4820294 G/G genotype exhibited
the highest transcript level of LGALS1 in human monocytes (P 5
0.031). Furthermore, we extracted the cis expression quantitative
trait loci (cis-eQTL) for LGALS1 from the lung eQTL dataset20. We
demonstrated that rs4820294 was a strong cis-eQTL for LGALS1 in
lung tissues of 1111 individuals (Figure 4d, meta-analysis P5 3.633
1025). Notably, in the absence of the partner SNP rs2899292, the
rs4820294 protective genotype G/G generated an association signal
at a P value of 5.203 1024 with an odds ratio of 2.67 for protection.
In both single-SNP analysis and SnipSnip analysis, rs13057866, a
SNP 2 kb upstream of LGALS1, emerged as one of the top hits.
rs13057866 was in high LD with rs2071769 (r2 5 1) and
rs34195652 (r2 $ 0.98) in Han Chinese (CHB), Asian (ASN) and
American (AMR, Figure 1). rs34195652, captured by our in-house
generated program IndelLDplot, is a T/TG indel 154 bp upstream
LGALS1. As shown in Figure 3, the region harboring rs2071769 and
rs34195652 has been defined as a strong regulatory region according
to the experimental evidence of ENCODEConsortium. According to
the functional annotation of HaploReg 2, the indel alters the regula-
torymotif of many putative transcription factors. It has been demon-
strated that the eQTLs proximate to the transcription start size tend
to be more conserved cross cell types and have stronger effect19.
Therefore, rs2071769 and rs34195652 are very likely the functional
variants that can tag rs13057866.
As mentioned above, in the single-SNP analysis, rs13057866 dis-
played a strong association signal with an allelic associationP value of
2.753 1026. The protective allele A was over-represented in control
group (29.3%) than in patient group (10.8%) with an odds ratio of
Table 2 | The top association anchor-partner SNPs identified with SnipSnip implementation
Anchor-partner SNP Anchor-partner Position (hg19) Annotation Artificial imputation P
rs646606| rs706481 57416633 | 57415200 C8B;chromosome 1 (intronic/intronic) 6.723 1028
rs13057866 | rs9622682 38069622 | 38074434 LGALS1; chromosome 22 (upstream/intronic) 1.813 1027
rs4820294 | rs2899292 38071043 | 38077718 LGALS1; chromosome 22 (upstream/intergenic) 2.133 1027
rs62236673 | rs2899292 38076063 | 38077718 LGALS1; chromosome 22 (downstream/intergenic) 4.253 1027
Table 3 | The haplotype analysis of rs4820294/rs2899292 for disease association in GWAS and LGALS1 expression association in
lymphoblast cell lines (LCLs)
Haplotype
Disease Association Expression Association in LCLs
Freq
OR (95% CI) P Freq PCase Control
AA 0.0207 0.0115 2.30 (0.34–15.50) 0.452 0.0277 6.863 1023
GA 0.4793 0.4225 1.28 (0.86–1.91) 0.245 0.5871 0.126
AG 0.3567 0.2102 2.10 (1.34–3.31) 9.033 1024 0.1817 0.465
GG 0.1433 0.3558 0.26 (0.15–0.45) 5.923 1027 0.2034 0.050
Freq, frequency; OR (95% CI), odds ratio (95% confidential interval).
www.nature.com/scientificreports
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0.29, which can be translated into 3.41 fold higher protection from
A(H7N9) infection to carriers of the allele A than the non-carriers.
Actually, rs13057866 A allele can mark rs4820294/rs2899292 GG
haplotype due to the complete linkage between rs13057866 and
rs4820294 (D’ 5 1.0) in all the queried populations (our cohort,
ASN, AMR and CHB) as well as the high LD between rs13057866
and rs2899292 in our study cohort (D’5 0.92) and other populations
(D’ $ 0.74, Figure 1). Specifically, rs13057866, rs4820294 and their
high LD variants form a high LD block in the regulatory region of
LGALS1 (Figure 1). Based on experimental evidence of ENCODE,
most of these variants are functional (supplementary Table 2).
Namely, the variants aggregated in the regulatory region form a
functional haplotype which may affect LGALS1 gene expression.
As mentioned above, the standard imputation in the region accom-
modating LGALS1 failed to obtain any variant with dramatically
increased association signal than rs13057866. Therefore, the ‘‘non-
genotyped causal variant’’ captured by SnipSnip implementation is
unlikely a single-locus variant. Instead, the functionally haplotype(s)
tagged by rs13057866, rs4820294 and their high LD variants are the
real causal variants which generated the strong association signals in
SnipSnip implementation (Table 2). Collectively, integrating our
experimental findings and data mining from the public databases,
we demonstrated that rs4820294, rs13057866 and their high LD
variants may jointly encode LGALS1 expression variations, thereby
caused the differential susceptibility to A(H7N9) infection among
humans.
The identification of biological pathways associated with A(H7N9)
infection. Pathway-based analysis or gene set enrichment analysis
have emerged as a powerful approach to overcome the limitation
of traditional single-SNP analysis of GWAS21, based on the concept
that genes do not work in isolation; functionally related genes in the
same molecular network or pathway are often involved in the disease
susceptibility22. In contrast with single-SNP association, pathway-
based analysis examines groups of functionally related genes, each
of whichmay have too small effect to be detected individually, but can
be detectable when analyzed as a functional group. In our study, all
the variants with P , 0.001 were mapped to 536 unique genes with
ANNOVAR23, which were then applied to a WEB-based GEne SeT
AnaLysis Toolkit (WebGestalt)24. WebGestalt was used to identify the
enriched pathways in association with the susceptibility to A(H7N9)
infection in Kyoto Encyclopedia of the Genes and Genomes (KEGG)
pathway collection, which consists of 390 well-defined categories. The
top two hits were the extracellular matrix (ECM)-receptor interaction
and mitogen-activated protein kinase (MAPK) signaling pathway
(Table 4). For example, there are totally 85 reference genes in the
ECM-receptor category. Among our gene set of 536 genes, 8
polymorphic genes fell in this category while the expected number
is 1.03 by chance. After correction for the multiple tests, the ECM-
receptor network represents a significantly enriched category with an
enrichment ratio of 7.76 and an adjusted P value of 0.0008. Similarly,
12 genes in our gene set were components of MAPK signaling
pathway with the enrichment ratio of 3.69 (adjusted P value 5
0.0045). Therefore, the gene set analysis suggested that ECM-
receptor interaction and MAPK signaling were the significantly
enriched pathways associated with the increased susceptibility to
the A(H7N9) infection.
Discussion
In this GWAS, we identified two polymorphic genes LGALS1 and
C8B as well as two biological pathways, ECM-receptor interaction
and MAPK signaling pathway, which are significantly associated
with the susceptibility to A(H7N9) infection. GWAS has been suc-
cessfully performed to identify the genetic variations associated with
the development of human diseases in an unbiased approach25.
However, the stringent genome-wide significance threshold and
the modest genetic effect size may mask the real associations26.
Figure 3 | The genetic architecture of LGALS1 gene.The upper panel denotes the chromosomal region that accommodates the LGALS1 gene. The region
flanking the transcriptional start site is a conserved regulatory region containing high LD SNPs in Chinese and other populations. The variants in high LD
with anchor SNPs, rs4820294 and rs13057866 (denoted withw), are shown in the next panel. The underlined variants are those in high LDwith rs4820294
while un-marked ones are in high LD with rs13057866. Lung eQTL panel shows the locations of eQTL and P values in -log10 scale. The horizontal bar
represents the -log10P value of 4. DNAse I hypersensitivity cluster and transcriptional factor binding site signals are annotated according to the
experimental data from ENCODE Consortium. The gray box indicates the extent of the hypersensitive region or cluster of transcriptional factor
occupancy. The darkness is proportional to the maximum signal strength observed in any cell line. The green line indicates the highest scoring site of an
identified canonical motif for the corresponding factor.
www.nature.com/scientificreports
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Both experimental and computational data support the notion that a
considerable proportion of trait-associated loci harbor variations
that impact the abundance of specific transcripts27. These express-
ion-related variations are referred as expression quantitative trait loci
(eQTLs), which have been mapped by paralleled genome-wide ana-
lysis of gene expression and genetic variations in LCLs28 and various
human tissues20,29. The local eQTLs (cis-eQTLs) refer to those within
1 Mb to the regulated gene. cis-eQTLs tend to have larger effect on
gene expression than distant eQTLs (trans-eQTLs)29. The availability
of systematically generated eQTLs has been widely leveraged to
prioritize the discovery of GWAS, facilitate the identification of cau-
sal genes and provide insight into the biological basis for the iden-
Figure 4 | The association variants of LGALS1 are correlated to differential expression levels in lymphoblastoid cell lines (LCLs), human monocytes
and lung tissues. (4a) Boxplot of LGALS1 mRNA expression according to rs4820294/rs2899292 haplotype GG in LCLs. The carriage of haplotype GG
significantly correlated to LGALS1mRNA expression (P5 0.050) in LCLs generated from 74ChineseHan fromBeijing (CHB). In x-axis, -/-, -/1, and1/
1 denote non-carriers (N5 49), heterozygotes (N5 21), and homozygotes (N5 4) of rs4820294/rs2899292 haplotype GG respectively. The box denotes
the interquartile range. The line and diamondwithin the box represent themedian and average respectively. Linear regression analysis was used to analyze
the data. (4b)Boxplot of LGALS1 protein expression corresponding to rs4820294/rs2899292 haplotype GG in 21 LCLs (N5 8 for -/-, 9 for -/1 and 4 for
1/1) by flow cytometry analysis. Carriage of rs4820294/rs2899292 haplotype GG significantly correlated to the LGALS1 protein expression in these LCLs
(P5 0.025). MFI, mean florescence intensity. (4c)The anchor SNP rs4820294, a variant in the proximal promoter of LGALS1, regulated LGALS1mRNA
expression. A total of 19 mRNA samples (N52 for genotype A/A, 8 for A/G and 9 for G/G) from peripheral blood monocytes expressed differential
levels of LGALS1 transcript in a genotype-specific manner (P 5 0.031) by RT-qPCR assay. Levels of LGALS1 transcript are normalized with those of
GAPDH. (4d) Gene expression levels of LGALS1 in human lung correlated to genotype groups of rs4820294 (meta-analysis P5 3.633 1025). The lung
cis-eQTL dataset has been generated from lung specimens collected at three centers examining a total of 1111 individuals. Denotations of boxplot are the
same as 4a, except that open dots represent the outliers.
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tified disease associations20,30. In this study, the identification of
rs4820294/rs2899292 haplotype GG and rs4820294 as eQTLs for
LGALS1 in LCLs and primary human cells adequately substantiates
their genetic association with the susceptibility to A(H7N9) infec-
tion. These results invariably underscore the role of LGALS1 to pro-
tect from human A(H7N9) infection.
LGALS1 contains conserved carbohydrate recognition domains to
distinctive patterns of carbohydrates on the surfaces of various micro-
organisms31. A recent study demonstrated that LGALS1 can bind to
various subtypes of influenza A viruses, inhibiting viral infectivity and
viral production. The mouse experiments showed that treatment with
LGALS1 reduced viral load, attenuated lung inflammation and
increased mouse survival. Moreover, the LGALS1-knockout mice
were more susceptible to the fatal influenza infection than wild-type
mice18. According to a public database Genevestigator, human
LGALS1 is highly expressed in plasma, variety of cells and tissues,
including upper and lower respiratory epithelium. The highly
expressed LGALS1 in bronchial epithelial cells displayed considerable
variations among 215 humans. In this study, we demonstrated that
genetic variants of LGALS1, including rs4820294 and rs13057866 and
the related variants, encode the higher expression of LGALS1 in
humans, which may confer the carriers of these variants more pro-
tection from A(H7N9) infection.
Our analysis revealed that two biological pathways, ECM-receptor
interaction and MAPK signaling, were significantly enriched path-
ways associated with the susceptibility to human A(H7N9) infection.
The extracellular matrix consists of a complex mixture of functional
macromolecules and provides structural and functional support to
the surrounding cells, including proteoglycans, non-proteoglycan
polysaccharide, collagens, fibronectin and laminin etc. The ECM
interacts with transmembrane receptors to mediate cellular activities
such as adhesion, migration, differentiation, proliferation and apop-
tosis. For example, fibronectins bind collagen and cell-surface integ-
rins, re-organize cell cytoskeleton to facilitate cell movement. ECM
and interacting proteins have been implicated in the entry of various
viruses including gamma-retrovirus, hepatitis B virus and rhabdo-
virus32,33. Specific components in ECM-receptor interaction pathway
have been implicated in the host-virus interaction of influenza
viruses. A recent study demonstrated the requirement of fibronectin
for the entry of influenza A virus34. Additionally, a focal adhesion
kinase links actin reorganization and thereby regulates influenza A
virus entry and replication35. The apoptosis signaling modulated
influenza A viruses to enable viral replication has been extensively
elucidated36. Collectively, cellular activities such as adhesion, dynamic
behaviors and apoptosis, which are regulated by ECM-receptor inter-
action, can affect the entry or replication of influenza viruses and
thereby influence the predisposition to human A(H7N9) infection.
The influenza A virus infection starts with the attachment of virion
to the receptor, followed by the efficient viral propagation in the host
cells37. Host genes or biological pathways required for viral entry and
viral replication have been identified14,38,39. The essential role of
MAPK signaling pathway for the replication of influenza A viruses
has been explicitly demonstrated38. Influenza virus inoculation in
transgenic mice with over-activated MAPK pathway resulted in
increased disease symptoms and higher mortality40. Additionally,
specific inhibitors for MAPK pathway displayed antiviral activity
against influenza A virus in vitro and in vivo41. The inbredmice study
revealed that host genetic components controlling viral replication
dynamics was primarily responsible for the host susceptibility to
H5N1 diseases37. In this GWAS, the identification of MAPK signal-
ing pathway as the significantly enriched category has advanced our
understanding that host factors and biological pathways involved in
viral replication represent one of critical determinants for human
susceptibility to A(H7N9) infection.
There exist limitations in this GWAS. One of them is the very
small sample size. Accordingly, the P values of most variants were
unable to meet the significance threshold for GWAS. However, con-
sidering that only about 400 human A(H7N9) influenza have been
reported, 102 cases are actually not a small number. Especially we
have 106 local healthy poultry workers who have been heavily
exposed to A(H7N9) viruses and serve as better controls than general
population in this study. Moreover, we are unable to replicate our
findings in a replication cohort, which is required for a standard
GWAS. A genetic association at the early stage of 2009 pandemic
H1N1 influenza encountered the same dilemma, in which 91 cases
and 98 controls were applied to a GWAS. In that study, the cutoff P
value was set as 1 3 1024 for the identification of susceptible var-
iants42. Apparently, we have identified the association variants with
more stringent criteria. Especially, some of variants identified in
this study have been substantiated with functional validation.
Nevertheless, further study with more A(H7N9) patients to replicate
the identified variants and enriched biological pathways are
warranted.
Most A(H7N9) patients primarily manifested as lower respiratory
tract infection. Our findings suggest that in affected individuals, the
A(H7N9) infection may be attributed to low levels of LGALS1 in the
respiratory tract. Additionally, the perturbed ECM-receptor inter-
action and MAPK signaling pathway, which are involved in viral
entry, viral replication and cellular apoptosis, may increase the sus-
ceptibility to A(H7N9) infection.
Methods
Characteristics of A(H7N9) patients and controls. This study has been approved by
the Institutional Review Board of the University of Hong Kong/Hospital Authority of
Table 4 | Enriched biological pathways in A(H7N9) patients versus healthy poultry workers with gene set analysis
Pathway name ECM-receptor interaction MAPK signaling pathway
laminin, alpha 4 (LAMA4) fibroblast growth factor 1 (FGF1)
collagen, type IV, alpha 1 (COL4A1) calcium channel, voltage-dependent, R type, alpha 1E subunit (CACNA1E)
synaptic vesicle glycoprotein 2B(SV2B) Rap guanine nucleotide exchange factor 2 (RAPGEF2)
thrombospondin 3 (THBS3) fibroblast growth factor 20 (FGF20)
integrin, beta 4 (ITGB4) phospholipase A2, group V (PLA2G5)
CD36 (thrombospondin receptor) fibroblast growth factor 12 (FGF12)
integrin, alpha 4(ITGA4) mitogen-activated protein kinase 8 interacting protein 3 (MAPK8IP3)
CD47 transforming growth factor, beta 2 (TGFB2)
mitogen-activated protein kinase kinase kinase 7 (MAP3K7)
neurotrophic tyrosine kinase, receptor, type 2 (NTRK2)
calcium channel, voltage-dependent, alpha 2/delta subunit 1 (CACNA2D1)
RAS p21 protein activator 1 (RASA1)
Ratio of Enrichment 7.76 3.69
Adjusted P 0.0008 0.0045
Ratio of enrichment represents the ratio of the number of genes in the gene set and also in the category versus the expected number of genes by chance. The adjusted P is the P value after correction for multiple tests.
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Hong Kong and the institutional review board of the First Affiliated Hospital, College
of Medicine, Zhejiang University. Patients with A(H7N9) infection were diagnosed
between March 2013 andMarch 2014. Human A(H7N9) infection was confirmed by
reverse transcription-polymerase chain reaction (RT-PCR) and/or viral culture.
Acute respiratory distress syndrome and multi-organ dysfunction syndrome were
defined with standard criteria43,44. The healthy poultry workers were sampled from
multiple live poultry markets located in 10 districts of Hangzhou, Zhejiang province.
Blood and nasal swab samples were collected from them with the written consent. All
experiments were carried out in accordance with relevant guidelines and approved
protocols.
Genotyping, quality control and data analysis. Genotyping was genome-widely
performed for .890 k SNPs using HumanOmniZhongHua-8 BeadChip (Illumina)
according to manufacturer’s specification. All participants in the dataset had
genotype missing rates,1%. The allelic association P values for SNPs were generated
using PLINK v1?0745. SNPs with more than 10% missing rate or minor allele
frequency less than 5%were removed from the association analysis. A total of 705,459
SNPs remained after quality control.
Imputation analysis, pathway-based analysis and LD analysis. All the variants in
our GWAS dataset were applied to the artificial imputation test using the SnipSnip
software with default parameters (fixed SNP window size, 10 SNPs; partner matrix,
multiplicative). The standard imputation was performed using program MACH
v1?046, with genotype data for 286 East-Asian samples (CHB, 97; CHS, 100;
JPT, 89) from 1000 Genomes Project released in June 2011 as reference panel.
The R package qqman was utilized to create Quantile-Quantile (Q-Q) plot and
Manhattan plot47. Haploview software was utilized to analyze and visualize the LD
pattern of the interested variants48. The in-house generated program indelLDplot49
(available at https://sourceforge.net/projects/indelldplot/files) was utilized to search
for functional SNPs, including indels, in high LD with user-interested variants
through mining the publically available 1000 Genomes and HapMap database. A
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) was used to identify the
enriched pathways24.
Cells and quantitative expression assays. Lymphoblast cell lines (LCLs) were
purchased from Coriell Institute for Medical Research. The cultured LCLs (13 106)
were fixed with 4% paraformaldehyde for 10 minutes, followed by permeabilization
with 0.1%Triton X-100. Cells were then immune-labelled with Rabbit anti-Galectin 1
(LGALS1, Abcam) and secondary antibody Goat anti-Rabbit Alexa 647. The
intracellular expression of LGALS1 was determined with a BD FACSCanto II flow
cytometer and data were analyzed with FlowJo (TreeStar). Peripheral blood
mononuclear cells preparation, monocyte separation and RT-qPCR assay were
performed as described previously13.
eQTL analysis and lung eQTLdataset.The linear regression analysis incorporated in
PLINK was used to examine the correlation of a specific LGALS1 genetic variant and
the quantitative expression in LCLs, human cells and tissues, using an addictive
model to estimate the effect of one copy increment of the variant. AP value# 0.05was
regarded as statistically significant. Lung eQTL dataset was generated as described
previously20. All patients who donated their lung tissue samples for generation of this
dataset have provided written informed consent.
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